183 related articles for article (PubMed ID: 11156582)
1. Combined blockade of endothelin-1 and thromboxane A(2) receptors against postischaemic contractile dysfunction in rat hearts.
Hornstein PS; Zaugg CE; Zhu P; Allegrini PR; Buser PT
Br J Pharmacol; 2001 Jan; 132(1):234-40. PubMed ID: 11156582
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.
Zaugg CE; Hornstein PS; Zhu P; Simper D; Lüscher TF; Allegrini PR; Buser PT
Circulation; 1996 Aug; 94(4):742-7. PubMed ID: 8772697
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Wang QD; Li XS; Lundberg JM; Pernow J
Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.
Gonon AT; Bulhak A; Bröijersén A; Pernow J
Br J Pharmacol; 2005 Mar; 144(6):860-6. PubMed ID: 15685207
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.
de Groot MC; Illing B; Horn M; Urban B; Haase A; Schnackerz K; Neubauer S
J Mol Cell Cardiol; 1998 Dec; 30(12):2657-68. PubMed ID: 9990537
[TBL] [Abstract][Full Text] [Related]
6. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
7. Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury.
Piuhola J; Kerkelä R; Keenan JI; Hampton MB; Richards AM; Pemberton CJ
Clin Sci (Lond); 2008 Feb; 114(4):293-304. PubMed ID: 17919123
[TBL] [Abstract][Full Text] [Related]
8. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
9. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
Xia Z; Kuo KH; McNeill JH; Ansley DM
Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest.
Goodwin AT; Amrani M; Gray CC; Chester AH; Yacoub MH
Eur J Cardiothorac Surg; 1997 May; 11(5):981-7. PubMed ID: 9196318
[TBL] [Abstract][Full Text] [Related]
11. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
Gonon AT; Wang QD; Pernow J
Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
[TBL] [Abstract][Full Text] [Related]
12. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart.
Wang QD; Li XS; Pernow J
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S445-7. PubMed ID: 8587441
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825
[TBL] [Abstract][Full Text] [Related]
14. Postischaemic reperfusion injury in the isolated rat heart: effect of ruthenium red.
Figueredo VM; Dresdner KP; Wolney AC; Keller AM
Cardiovasc Res; 1991 Apr; 25(4):337-42. PubMed ID: 1715813
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin.
Zhu P; Zaugg CE; Simper D; Hornstein P; Allegrini PR; Buser PT
Cardiovasc Res; 1995 May; 29(5):658-63. PubMed ID: 7606754
[TBL] [Abstract][Full Text] [Related]
16. Histamine release and its effects in ischaemia-reperfusion injury of the isolated rat heart.
Valen G; Kaszaki J; Szabo I; Nagy S; Vaage J
Acta Physiol Scand; 1994 Apr; 150(4):413-24. PubMed ID: 7518635
[TBL] [Abstract][Full Text] [Related]
17. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
18. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.
Sakanashi M; Sakanashi M; Sugahara K; Sakanashi M
Clin Exp Pharmacol Physiol; 2007; 34(1-2):55-60. PubMed ID: 17201736
[TBL] [Abstract][Full Text] [Related]
19. A pyrroline derivative of mexiletine offers marked protection against ischemia/reperfusion-induced myocardial contractile dysfunction.
Li H; Xu KY; Zhou L; Kalai T; Zweier JL; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2000 Nov; 295(2):563-71. PubMed ID: 11046089
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptor stimulation by carbachol improves functional recovery in isolated, blood perfused rabbit heart.
Hendrikx M; Toshima Y; Mubagwa K; Flameng W
Cardiovasc Res; 1993 Jun; 27(6):980-9. PubMed ID: 8221789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
